Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a 'Case Study'
about
Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy.The renal effects of SGLT2 inhibitors and a mini-review of the literature.Diabetes drugs and the incidence of solid cancers: a survey of the current evidence.SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials.Revitalization of pioglitazone: the optimum agent to be combined with a sodium-glucose co-transporter-2 inhibitor.SGLT2 Inhibitors: Benefit/Risk Balance.Saxagliptin/Dapagliflozin: A Review in Type 2 Diabetes Mellitus.Effects of sodium-glucose co-transporter 2 inhibitors on metabolism: unanswered questions and controversies.SGLT2 inhibitors: are they safe?Dapagliflozin and saxagliptin tablets for adults with type 2 diabetes.Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials.Dapagliflozin/Saxagliptin Fixed-Dose Tablets: A New Sodium-Glucose Cotransporter 2 and Dipeptidyl Peptidase 4 Combination for the Treatment of Type 2 Diabetes.SGLT2 inhibitors and cancer: why further evidence is required.
P2860
Q33756414-25AB7F7D-BADF-41F9-9146-107EEE93A8B3Q37632127-684E7343-9A38-4D53-9027-948204E8A728Q38651175-85DE385C-22BE-4EEC-A59F-9FFDF04F4C07Q38654762-B3312BC6-070B-475B-A965-4CEFD5633ECDQ38751451-A699D638-851B-468E-B43E-C13A72AC8531Q38931842-AC998844-72F2-4C5B-AD80-6C921D53A70CQ38972958-C6849E77-3CDD-471A-A481-7A407DA013F7Q39000587-E098B549-93D4-4C61-87DA-E66DC329A79BQ47642298-69AA63E1-BAB7-46E5-8620-912990675E02Q47687852-05B7FE33-A2D3-4AF6-A600-159008DD8E44Q47918474-75FD6280-38DE-4A06-B537-6FC9D5742309Q48015498-762627ED-2FB3-48CE-86BE-5A2108BAC366Q50110191-886CED2D-E515-464E-B259-AA9927874AC2
P2860
Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a 'Case Study'
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Assessing Bladder Cancer Risk ...... ment Program as a 'Case Study'
@ast
Assessing Bladder Cancer Risk ...... ment Program as a 'Case Study'
@en
type
label
Assessing Bladder Cancer Risk ...... ment Program as a 'Case Study'
@ast
Assessing Bladder Cancer Risk ...... ment Program as a 'Case Study'
@en
prefLabel
Assessing Bladder Cancer Risk ...... ment Program as a 'Case Study'
@ast
Assessing Bladder Cancer Risk ...... ment Program as a 'Case Study'
@en
P2093
P2860
P1433
P1476
Assessing Bladder Cancer Risk ...... ment Program as a 'Case Study'
@en
P2093
Agata Ptaszynska
Edward M Messing
Eva Johnsson
Kristina Johnsson
Samuel M Cohen
Timothy P Reilly
P2860
P2888
P304
P356
10.1007/S13300-015-0128-9
P577
2015-09-01T00:00:00Z